Health
Opinion: Advocating for safe and effective meds
The following opinion piece about the Prescription Drug User Fee Act reauthorization appeared in The Hill's Congress Blog in September, co-authored by NCL Executive Director Sally Greenberg and Myrl Weinberg, President of the National Health Council.
Examining the Prescription Drug User Fee Act
NCL's Sally Greenberg testified before the FDA recently about the re-authorization of the Prescription Drug User Fee Act, calling on the federal agency to seize this opportunity to critically examine the impact of the program, and make meaningful changes to enhance the safety of drugs in this country.
NCL forum explores biologics pathway
Access to safe and affordable medications has long been a priority of NCL. It is especially important now as consumers increasingly rely on pharmaceutical and biotechnology products to enhance and prolong their lives. Due both to increased utilization and product costs, the amount consumers spend on these therapeutics has increased significantly in the last decade.
Browse Topics in Health
- Alcohol: labeling
- Alcohol: teen drinking
- Allergies
- Anti-aging products and procedures
- Asthma
- Autism
- Cholesterol drugs
- Cough and cold remedies
- Counterfeit drugs
- Dental care
- Dietary supplements
- Drug substitution
- En Español
- Evidence-based medicine
- Flu shots
- Food-drug interactions
- Health care reform
- Healthy kids
- Heart disease
- Hormones
- Information technology
- Insurance
- Medication adherence
- Mental health
- Obesity
- Osteoporosis
- Over-the-counter medicines
- Prescription drugs
- Privacy
- Retail health clinics
- Safety
- Vision care
NCL's Fraud Center
Our fraud team tracks the latest Internet and telemarketing scams, and helps consumers avoid them.
Stop Child Labor
Rx Adherence
Bookmark This
Follow Us
